Good practice guidelines for the use of statistical regression models in economic evaluations
- PMID: 23807751
- DOI: 10.1007/s40273-013-0069-y
Good practice guidelines for the use of statistical regression models in economic evaluations
Abstract
Decision-analytic models (DAMs) used to evaluate the cost effectiveness of interventions are pivotal sources of evidence used in economic evaluations. Parameter estimates used in the DAMs are often based on the results of a regression analysis, but there is little guidance relating to these. This study had two objectives. The first was to identify the frequency of use of regression models in economic evaluations, the parameters they inform, and the amount of information reported to describe and support the analyses. The second objective was to provide guidance to improve practice in this area, based on the review. The review concentrated on a random sample of economic evaluations submitted to the UK National Institute for Health and Clinical Excellence (NICE) as part of its technology appraisal process. Based on these findings, recommendations for good practice were drafted, together with a checklist for critiquing reporting standards in this area. Based on the results of this review, statistical regression models are in widespread use in DAMs used to support economic evaluations, yet reporting of basic information, such as the sample size used and measures of uncertainty, is limited. Recommendations were formed about how reporting standards could be improved to better meet the needs of decision makers. These recommendations are summarised in a checklist, which may be used by both those conducting regression analyses and those critiquing them, to identify what should be reported when using the results of a regression analysis within a DAM.
Similar articles
-
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment.Pharmacoeconomics. 2006;24(4):355-71. doi: 10.2165/00019053-200624040-00006. Pharmacoeconomics. 2006. PMID: 16605282 Review.
-
Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.Health Technol Assess. 2021 Dec;25(76):1-228. doi: 10.3310/hta25760. Health Technol Assess. 2021. PMID: 34990339
-
Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.Health Technol Assess. 2013 Dec;17(58):v-vi, 1-192. doi: 10.3310/hta17580. Health Technol Assess. 2013. PMID: 24325843 Free PMC article.
-
The use of economic evaluations in NHS decision-making: a review and empirical investigation.Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175. doi: 10.3310/hta12070. Health Technol Assess. 2008. PMID: 18373906
-
Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment.Int Psychogeriatr. 2018 Nov;30(11):1593-1605. doi: 10.1017/S1041610218001291. Int Psychogeriatr. 2018. PMID: 30475198
Cited by
-
Health state utility values in patients with Ankylosing Spondylitis: a systematic review and meta-analysis.Qual Life Res. 2024 Sep;33(9):2321-2334. doi: 10.1007/s11136-024-03670-8. Epub 2024 Jun 1. Qual Life Res. 2024. PMID: 38824212
-
Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations.Pharmacoeconomics. 2023 Jun;41(6):619-632. doi: 10.1007/s40273-023-01242-1. Epub 2023 Mar 21. Pharmacoeconomics. 2023. PMID: 36943674 Free PMC article. Review.
-
Protocol for the economic evaluation of the diarrhea alleviation through zinc and oral rehydration salt therapy at scale through private and public providers in rural Gujarat and Uttar Pradesh, India.Implement Sci. 2014 Nov 19;9:164. doi: 10.1186/s13012-014-0164-2. Implement Sci. 2014. PMID: 25407053 Free PMC article.
-
Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.Health Technol Assess. 2020 Jun;24(34):1-68. doi: 10.3310/hta24340. Health Technol Assess. 2020. PMID: 32613941 Free PMC article.
-
Mapping of Family Reported Outcome Measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values.Qual Life Res. 2024 Apr;33(4):1107-1119. doi: 10.1007/s11136-023-03590-z. Epub 2024 Feb 25. Qual Life Res. 2024. PMID: 38402530 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources